Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 4/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 4/20 | 1.00 |
| ▸ | CHRM3 | P20309 | 4/20 | 1.00 |
| ▸ | CHRM4 | P08173 | 1/20 | 1.00 |
| ▸ | CHRM5 | P08912 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinuclidinyl Benzilate SCHEMBL241173 | 1.00 | CHRM2 (1.00) | CHRM2CHRM1CHRM3CHRM4CHRM5 | |
| Quinuclidinyl Benzilate SCHEMBL29433215 | 0.99 | CHRM2 (0.97) | CHRM2CHRM1CHRM3CHRM4CHRM5 | |
| SCHEMBL9848226 | 0.93 | CHRM2 (0.86) | CHRM2CHRM1CHRM3CHRM4CHRM5 | |
| SCHEMBL9145154 | 0.93 | CHRM2 (0.86) | CHRM2CHRM1CHRM3CHRM4CHRM5 | |
| SCHEMBL9146007 | 0.93 | CHRM2 (0.86) | CHRM2CHRM1CHRM3CHRM4CHRM5 | |
| SCHEMBL9148881 | 0.93 | CHRM2 (0.86) | CHRM2CHRM1CHRM3CHRM4CHRM5 | |
| SCHEMBL9146124 | 0.93 | CHRM2 (0.86) | CHRM2CHRM1CHRM3CHRM4CHRM5 | |
| SCHEMBL10814164 | 0.93 | CHRM2 (0.86) | CHRM2CHRM1CHRM3CHRM4CHRM5 | |
| SCHEMBL8529194 | 0.93 | CHRM2 (0.86) | CHRM2CHRM1CHRM3CHRM4CHRM5 | |
| SCHEMBL10817618 | 0.93 | CHRM2 (0.86) | CHRM2CHRM1CHRM3CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1050 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090545-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES | UNIV MANITOBA (CA) | 2025-03-20 | — | — | US | claimed |
| US-11717532-B2 | Methods and compositions for treating wounds utilizing chitosan compounds | SYNEDGEN, INC. (US) | 2023-08-08 | — | — | US | claimed |
| EP-4178948-A2 | FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF | Universidade de Santiago de Compostela (ES) | 2023-05-17 | — | — | EP | claimed |
| WO-2022023496-A2 | FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2022-02-03 | — | — | WO | claimed |
| US-20220026427-A1 | CELL BASED ASSAYS AND KITS FOR ASSESSING SERUM CHOLINERGIC RECEPTOR ACTIVITY | CENTRE FOR ADDICTION AND MENTAL HEALTH (CA) | 2022-01-27 | — | — | US | claimed |
| EP-3900712-A1 | GPCR HETEROMER INHIBITORS AND USES THEREOF | GPCR Therapeutics, Inc. (KR) | 2021-10-27 | — | — | EP | claimed |
| EP-3895705-A2 | METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES | University of Manitoba (CA) | 2021-10-20 | — | — | EP | claimed |
| EP-3727371-A1 | GPCR HETEROMER INHIBITORS AND USES THEREOF | GPCR Therapeutics, Inc. (KR) | 2020-10-28 | — | — | EP | claimed |
| CN-111741752-A | GPCR heteromer inhibitors and uses thereof | GPCR治疗公司 | 2020-10-02 | — | — | CN | claimed |
| US-10207993-B2 | Compounds as anti-tubercular agents | SPHAERA PHARMA PVT. LTD. (IN) | 2019-02-19 | — | — | US | claimed |
| EP-0757694-A4 | THIOETHER COMPOUNDS FOR USE IN PREPARING BIFUNCTIONAL CHELATING AGENTS FOR THERAPEUTIC RADIOPHARMACEUTICALS | UNIV MISSOURI (US) | 1998-05-06 | — | — | EP | claimed |
| EP-0629617-B1 | Heteroatom-bearing ligands and metal complexes thereof | BRACCO INT BV (NL) | 1998-04-29 | — | — | EP | claimed |
| EP-0757694-A1 | THIOETHER COMPOUNDS FOR USE IN PREPARING BIFUNCTIONAL CHELATING AGENTS FOR THERAPEUTIC RADIOPHARMACEUTICALS | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 1997-02-12 | — | — | EP | claimed |
| US-5569447-A | TOMOGRAPHIC IMAGING AGENTS | THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-10-29 | — | — | US | claimed |
| WO-1995029925-A1 | THIOETHER COMPOUNDS FOR USE IN PREPARING BIFUNCTIONAL CHELATING AGENTS FOR THERAPEUTIC RADIOPHARMACEUTICALS | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 1995-11-09 | — | — | WO | claimed |
| US-5387409-A | Diagnostic imaging agents, e.g. hypoxic tissue; radiotherapy; kits | BRACCO INTERNATIONAL B.V. (NL) | 1995-02-07 | — | — | US | claimed |
| US-5100477-A | Macroporous Crosslinked Hydrophobic Copolymer | DOW CORNING CORPORATION (US) | 1992-03-31 | — | — | US | claimed |
| EP-0441491-A1 | Boronic acid adducts of rhenium dioxime and technetium-99M dioxime complexes containing a biochemically active group | BRACCO INTERNATIONAL B.V. (NL) | 1991-08-14 | — | — | EP | claimed |
| US-4676880-A | DECARBONYLATION, DETECTING MICROQUANTITILES OF TOXIC A,A-DIAR YGLYCOLATE ESTERS, FORMING VISIBLE COLOR | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1987-06-30 | — | — | US | claimed |
| US-4299813-A | DETERMINING LEVELS OF TRICYCLIC ANTIDEPRESSANT BY MEASURING INHIBITION TO BINDING OF RADIOACTIVE MUSCARINIC CHOLINERGIC | NOVA PHARMACEUTICAL CORPORATION; A CORP OF DE. | 1981-11-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10207993-B2 | Compounds as anti-tubercular agents | FNTB, G6PD, PGGT1B | CHRM2 2407/4885CHRM1 2034/4885CHRM3 2760/4885 |
| US-20250090545-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES | PMP22, CHRNA7, CHRNB3 | CHRM2 12/4885CHRM1 35/4885CHRM3 16/4885 |
| US-11717532-B2 | Methods and compositions for treating wounds utilizing chitosan compounds | CHIA, MMP8, CHIT1 | CHRM2 2321/4885CHRM1 3139/4885CHRM3 1400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.